Skip to main content

Advertisement

SpringerLink
Log in

Cardiovascular impact of exercise and drug therapy in older hypertensives with coronary heart disease: PREHACOR study

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Our aim in this study was to examine the relationship between regular exercise and major cardiovascular events in hypertensive elderly with established coronary heart disease (CHD) in the primary care setting. The PREHACOR study recruited 3193 hypertensive patients, aged 74 ± 6 years, 67% male, with CHD. Regular exercise assessed by questionnaire was defined as recreational activity >20 min/day, >3 times/week. Endpoints at 6 months were new cardiovascular events (NCEs: myocardial infarction and hospitalization for stroke, unstable angina, congestive heart failure, or coronary revascularization). New cardiovascular events occurred in 376 patients (11.8%), with 17 deaths (0.5%). New cardiovascular events patients were older, with higher body mass index, and were more likely to have diabetes, arrhythmia, history of congestive heart failure, and noncardiac organ damage than non-NCE patients. Blood pressure was significantly and similarly reduced in both groups. Multivariate logistic regression associated NCEs positively and independently with a history of congestive heart failure (odds ratio [OR] 2.50; confidence interval [CI] = 1.9–3.23), noncardiac target organ damage (OR 1.51; CI = 1.20–1.90), and beta-blocker use (OR 1.28; CI = 1.02–1.59), and inversely and independently with combination low-dose angiotensin converting enzyme inhibitor + diuretic therapy (OR 0.66; CI = 0.45–0.95) and regular exercise (OR 0.70; CI = 0.54–0.90). Regular exercise is significantly associated with fewer major cardiovascular events in hypertensive elderly subjects with established CHD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Staessen JA, Wang JG, Thijs L (2001) Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 358:1305–1315

    Article  PubMed  CAS  Google Scholar 

  2. Safar ME, Vaisse B, Blacher J, Rudnichi A, Mourad JJ (2004) Pulse pressure monitoring of open antihypertensive therapy. Am J Hypertens 17:1088–1094

    Article  PubMed  CAS  Google Scholar 

  3. Asmar R, Safar M, Queneau P (2001) Evaluation of the placebo effect and reproducibility of blood pressure measurement in hypertension. Am J Hypertens 14:546–552

    Article  PubMed  CAS  Google Scholar 

  4. McMurray J (2000) Heart failure: we need more trials in typical patients. Eur Heart J 21:699–700

    Article  PubMed  CAS  Google Scholar 

  5. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981–2997

    Article  Google Scholar 

  6. Cornelissen VA, Fagard RH (2005) Effect of resistance training on resting blood pressure: a meta-analysis of randomized controlled trials. J Hypertens 23:251–259

    Article  PubMed  CAS  Google Scholar 

  7. Manson JE, Greenland P, LaCroix AZ, Stefanick ML, Mouton CP, Oberman A, Perri MG, Sheps DS, Pettinger MB, Siscovick DS (2002) Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 347:716–725

    Article  PubMed  Google Scholar 

  8. Rauramaa R, Halonen P, Vaisanen SB, Lakka TA, Schmidt-Trucksäss A, Berg A, Penttilä IM, Rankinen T, Bouchard C (2004) Effects of aerobic physical exercise on inflammation and atherosclerosis in men: the DNASCO Study: a six-year randomized, controlled trial. Ann Intern Med 140:1007–1014

    PubMed  Google Scholar 

  9. Witham MD, Struthers AD, McMurdo ME (2003) Exercise training as a therapy for chronic heart failure: can older people benefit? J Am Geriatr Soc 51:699–709

    Article  PubMed  Google Scholar 

  10. Wannamethee SG, Shaper AG, Walker M (2000) Physical activity and mortality in older men with diagnosed coronary heart disease. Circulation 102:1358–1363

    PubMed  CAS  Google Scholar 

  11. Iwai N, Hisamichi S, Hayakawa N, Inaba Y, Nagaoka T, Sugimori H, Seki N, Sakata K, Suzuki K, Tamakoshi A, Nakamura Y, Yamamoto A, Nishino Y, Ogihara A, Okamoto N, Suzuki H, Morioka S, Ito Y, Wakai K, Ojima T, Tanaka H, Nose T, Ohno Y (2001) Validity and reliability of single-item questions about physical activity. J Epidemiol 11:211–218

    PubMed  CAS  Google Scholar 

  12. Law MR, Wald NJ, Morris JK, Jordan RE (2003) Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 326:1427–1435

    Article  PubMed  CAS  Google Scholar 

  13. Psaty BM, Lumley T, Furberg CD (2004) Meta-analysis of health outcomes of chlorthalidone-based vs nonchlorthalidone-based low-dose diuretic therapies. JAMA 292:43–44

    Article  PubMed  CAS  Google Scholar 

  14. Psaty BM, Kuller LH, Bild D, Burke GL, Kittner SJ, Mittelmark M, Price TR, Rautaharju PM, Robbins J (1995) Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol 5:270–277

    Article  PubMed  CAS  Google Scholar 

  15. Belardinelli R, Georgiou D, Cianci G, Purcaro A (1999) Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation 99:1173–1182

    PubMed  CAS  Google Scholar 

  16. Tanaka H, Safar ME (2005) Influence of lifestyle modifications on arterial stiffness and wave reflections. Am J Hypertens 18:137–144

    Article  PubMed  Google Scholar 

  17. Wagner A, Simon C, Evans A, Ducimetière P, Bongard V, Montaye M, Arveiler D, PRIME Study Group (2003) Physical activity patterns in 50–59 year men in France and Northern Ireland. Associations with socio-economic status and health behaviour. Eur J Epidemiol 18:321–329

    Article  PubMed  CAS  Google Scholar 

  18. Sundquist K, Qvist J, Sundquist J, Johansson SE (2004) Frequent and occasional physical activity in the elderly: a 12-year follow-up study of mortality. Am J Prev Med 27:22–27

    Article  PubMed  Google Scholar 

  19. Mourad JJ, Pannier B, Blacher J, Rudnichi A, Benetos A, London GM, Safar ME (2001) Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 59:1834–1841

    Article  PubMed  CAS  Google Scholar 

  20. Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Hulley SB, Grady D, Shlipak MG (2004) Predictors of heart failure among women with coronary disease. Circulation 110:1424–1430

    Article  PubMed  Google Scholar 

  21. Smulyan H, Safar ME (2000) The diastolic blood pressure in systolic hypertension. Ann Intern Med 132:233–237

    PubMed  CAS  Google Scholar 

  22. Haider AW, Larson MG, Franklin SS, Levy D (2003) Framingham Heart Study. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 138:10–16

    PubMed  Google Scholar 

  23. Blacher J, Evans A, Arveiler D, Amouyel P, Ferrières J, Bingham A, Yarnell J, Haas B, Montaye M, Ruidavets JB, Ducimetière P (2004) Hyperlipidaemia in the population: the PRIME study. J Hypertens 22:415–423

    Article  PubMed  CAS  Google Scholar 

  24. Lindholm LH, Carlberg B, Samuelsson O (2005) Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 366:1545–1553

    Article  PubMed  CAS  Google Scholar 

  25. London GM, Asmar RG, O’Rourke MF, Safar ME (2004) REASON Project Investigators. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 43:92–99

    Article  PubMed  CAS  Google Scholar 

  26. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O’Rourke M (2006) CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 113:1213–1225

    Article  PubMed  CAS  Google Scholar 

  27. Siscovick DS, Raghunathan TE, Psaty BM, Koepsell TD, Wicklund KG, Lin X, Cobb L, Rautaharju PM, Copass MK, Wagner EH (1994) Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 330:1852–1857

    Article  PubMed  CAS  Google Scholar 

  28. Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS (2003) Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 289:2534–2544

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Avicenne Hospital, AP-HP and Paris XIII University (EA 3412), Bobigny, France

    Jean-Jacques Mourad

  2. Georges Pompidou Hospital, Paris, France

    Nicolas Danchin

  3. Rangueil Hospital, Toulouse, France

    Jacques Puel

  4. Gonesse Hospital, Gonesse, France

    Hervé Gallois

  5. Gecem, Montrouge, France

    Jérôme Msihid

  6. Centre de Diagnostic, Hôpital Hôtel-Dieu, 1 place du Parvis Notre-Dame, 75181, Paris Cedex 04, France

    Michel E. Safar

  7. University of Wisconsin-Madison, Madison, WI, USA

    Hirofumi Tanaka

Authors
  1. Jean-Jacques Mourad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicolas Danchin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jacques Puel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hervé Gallois
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jérôme Msihid
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michel E. Safar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hirofumi Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michel E. Safar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mourad, JJ., Danchin, N., Puel, J. et al. Cardiovascular impact of exercise and drug therapy in older hypertensives with coronary heart disease: PREHACOR study. Heart Vessels 23, 20–25 (2008). https://doi.org/10.1007/s00380-007-1004-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-007-1004-y

Key words

Search

Navigation